Abattis Bioceuticals Revenue

In the fiscal year ending September 30, 2019, Abattis Bioceuticals had annual revenue of 356.88K CAD with 4,163.24% growth. Abattis Bioceuticals had revenue of 226.27K in the quarter ending September 30, 2019, with 9,064.32% growth.

Revenue

356.88K CAD

Revenue Growth

+4,163.24%

P/S Ratio

0.00

Revenue / Employee

n/a

Employees

n/a

Market Cap

476.00 USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2019	356.88K	348.51K	4,163.24%
Sep 30, 2018	8.37K	-	-
Sep 30, 2017	-	-	-
Sep 30, 2016	-	-	-
Sep 30, 2015	91.94K	84.22K	1,090.93%
Sep 30, 2014	Pro	Pro	Pro
Sep 30, 2013	Pro	Pro	Pro
Sep 30, 2012	Pro	Pro	Pro
Sep 30, 2011	Pro	Pro	Pro
Sep 30, 2010	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Flower One Holdings	43.07M
Choom Holdings	15.05M
The Flowr Corporation	9.05M
Radient Technologies	2.33M
Beleave	2.23M
Sproutly Canada	416.79K
Ionic Brands	21.39M
Item 9 Labs	19.69M

Revenue Rankings